US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

20.86

+0.51002.51%

Volume:14.79K

Turnover:305.58K

Market Cap:79.86M

PE:-0.79

High:21.18

Open:20.51

Low:20.25

Close:20.35

52wk High:37.50

52wk Low:18.19

Shares:3.83M

Float Shares:1.07M

Volume Ratio:2.01

T/O Rate:1.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-26.3603

EPS(LYR):-23.0359

ROE:-333.84%

ROA:-49.98%

PB:-53.21

PE(LYR):-0.91

Loading ...

Overview Company News Filings

Pelthos Therapeutics Hosts Annual Shareholder Meeting, Quorum Present

OS Therapies Names Kerry Clem Chief Commercial Officer

Analysts Offer Insights on NA Companies: Flex (FLEX), Howard Hughes Holdings (HHH) and Pelthos Therapeutics (PTHS)

Analysts Offer Insights on NA Companies: Pelthos Therapeutics (PTHS) and X-Energy, Inc. Class A (XE)

Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)

Pelthos Therapeutics Announces Annual Shareholder Meeting

Scienture Q2 Revenue Surges on Rezenopy Launch

Pelthos Therapeutics (PTHS) Gets a Buy from Alliance Global Partners

Pelthos Therapeutics Falls as Co Says Will Restate Q1 Financial Statements

Biofrontera Q2 Revenue Rises on Higher Volume, Pricing

Pelthos Therapeutics Posts Investor Deck Outlining Dermatology Portfolio Strategy Centered on Zelsuvmi Launch, Xepi and Xeglyze Additions

Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption

Pelthos Q2 FY26 Net Loss Narrows to $23.42 Million; Net Product Revenue Climbs 45% to $15.4 Million

Pelthos Therapeutics Q2 Net Income USD -23.417 Million

THOMSON REUTERS

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results

THOMSON REUTERS

Pelthos Therapeutics Restates Q1 2026 Net Loss to USD 25.07 Million

Pelthos Restates Q1 Results After ASC 820 Error Lifts Convertible Debt Fair Value by $15.8 Million

Pelthos Therapeutics - Restatement Will not Impact Liquidity or Cash Position for Quarter Ended March 31, 2026 - SEC Filing

THOMSON REUTERS

Pelthos Therapeutics - Financial Statements Should no Longer be Relied upon for Quarter Ended March 31- SEC Filing

THOMSON REUTERS

Pelthos Therapeutics - Identifies Material Weakness in Internal Control as of March 31, 2026 - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PTHS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":20.86,"timestamp":1790957571043,"preClose":20.35,"halted":0,"volume":14789,"delay":0,"changeRate":0.02506142506142496,"floatShares":1065500,"shares":3828500,"eps":-26.360256,"marketStatus":"Trading","change":0.51,"latestTime":"10-02 12:15:03 EDT","open":20.51,"high":21.18,"low":20.25,"amount":305576.588536,"amplitude":0.0457,"askPrice":21.53,"askSize":100,"bidPrice":20.68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-26.360256,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":20.35,"preHourTrading":{"tag":"盘前","latestPrice":19.87,"preClose":20.35,"latestTime":"07:11 EDT","volume":2,"amount":39.74,"timestamp":1790939486524,"change":-0.48,"changeRate":-0.023587,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":20.35,"preClose":20.35,"latestTime":"16:10 EDT","volume":6,"amount":122.1,"timestamp":1790885404237,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.012001},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1065500,"roa":"-49.98%","roe":"-333.84%","lyrEps":-23.035919,"volumeRatio":2.012001,"shares":3828500,"dividePrice":0,"high":21.18,"amplitude":0.0457,"preClose":20.35,"low":20.25,"week52Low":18.19,"pbRate":"-53.21","psRate":"1.84","week52High":37.5,"institutionHeld":0,"latestPrice":20.86,"eps":-26.360256,"divideRate":0,"volume":14789,"delay":0,"ttmEps":-26.360256,"open":20.51,"prevYearClose":31,"prevWeekClose":22.19,"prevMonthClose":21.01,"prevQuarterClose":21.01,"fiveDayClose":22.19,"twentyDayClose":24.36,"sixtyDayClose":27.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PTHS","fiscalQuarterEnding":"2026/06","expectedEps":-3.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-6.62},{"market":"US","date":"2026-05-14","symbol":"PTHS","fiscalQuarterEnding":"2026/03","expectedEps":4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-3.09},{"market":"US","date":"2026-03-19","symbol":"PTHS","fiscalQuarterEnding":"2025/12","expectedEps":-3.95,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-2.83},{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-10-01","current":-0.795895,"percent":0.990415,"low":-12.702408,"twenty":-3.718472,"median":-1.957787,"eighty":-1.713738,"high":-0.860599,"avg":-3.673925,"sd":3.294556,"marketCap":80436133},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-27","current":-3.155779,"twenty":-10.602805,"median":-3.390837,"eighty":-1.970524,"marketCap":74417489},{"date":"2026-03-06","current":-3.074826,"twenty":-10.434506,"median":-3.374475,"eighty":-1.97142,"marketCap":72508518},{"date":"2026-03-13","current":-3.190081,"twenty":-10.434506,"median":-3.360076,"eighty":-1.972316,"marketCap":75226374},{"date":"2026-03-20","current":-1.7154,"twenty":-10.097909,"median":-3.349516,"eighty":-1.97142,"marketCap":74309421},{"date":"2026-03-27","current":-1.761468,"twenty":-9.761313,"median":-3.316998,"eighty":-1.911381,"marketCap":76305047},{"date":"2026-04-02","current":-1.649924,"twenty":-9.626674,"median":-3.312954,"eighty":-1.88181,"marketCap":71473065},{"date":"2026-04-10","current":-1.749075,"twenty":-9.525695,"median":-3.297807,"eighty":-1.833421,"marketCap":75768160},{"date":"2026-04-17","current":-1.781608,"twenty":-9.500787,"median":-3.280885,"eighty":-1.792379,"marketCap":77177489},{"date":"2026-04-24","current":-1.797101,"twenty":-9.439526,"median":-3.26405,"eighty":-1.781608,"marketCap":77848597},{"date":"2026-05-01","current":-1.936531,"twenty":-9.424716,"median":-3.220673,"eighty":-1.782538,"marketCap":83888575},{"date":"2026-05-08","current":-1.938855,"twenty":-9.37086,"median":-3.190081,"eighty":-1.785296,"marketCap":83989241},{"date":"2026-05-15","current":-2.144901,"twenty":-9.354703,"median":-3.188002,"eighty":-1.78619,"marketCap":92914985},{"date":"2026-05-22","current":-1.825776,"twenty":-9.310946,"median":-3.162639,"eighty":-1.782538,"marketCap":94189979},{"date":"2026-05-29","current":-1.738193,"twenty":-9.201215,"median":-3.155779,"eighty":-1.782305,"marketCap":89671641},{"date":"2026-06-05","current":-1.742235,"twenty":-9.106968,"median":-3.138864,"eighty":-1.781608,"marketCap":89880179},{"date":"2026-06-12","current":-1.934919,"twenty":-9.053119,"median":-3.057709,"eighty":-1.781608,"marketCap":99820524},{"date":"2026-06-18","current":-1.819713,"twenty":-9.002347,"median":-3.051164,"eighty":-1.781608,"marketCap":93877171},{"date":"2026-06-26","current":-1.967931,"twenty":-8.742683,"median":-3.016477,"eighty":-1.781608,"marketCap":101523590},{"date":"2026-07-02","current":-1.886411,"twenty":-8.328756,"median":-3.009278,"eighty":-1.781608,"marketCap":97318060},{"date":"2026-07-10","current":-1.829819,"twenty":-7.979401,"median":-2.945794,"eighty":-1.781608,"marketCap":94398518},{"date":"2026-07-17","current":-1.799501,"twenty":-7.934399,"median":-2.91896,"eighty":-1.781608,"marketCap":92834477},{"date":"2026-07-24","current":-1.91336,"twenty":-7.821168,"median":-2.887545,"eighty":-1.781608,"marketCap":98708318},{"date":"2026-07-31","current":-1.76851,"twenty":-7.788854,"median":-2.833747,"eighty":-1.781608,"marketCap":91235681},{"date":"2026-08-07","current":-1.9841,"twenty":-7.738365,"median":-2.592541,"eighty":-1.781608,"marketCap":102357745},{"date":"2026-08-14","current":-1.950414,"twenty":-7.559968,"median":-2.325379,"eighty":-1.781608,"marketCap":100619922},{"date":"2026-08-21","current":-1.18144,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"marketCap":102066983},{"date":"2026-08-28","current":-1.107877,"twenty":-4.131996,"median":-1.987469,"eighty":-1.771879,"marketCap":95711725},{"date":"2026-09-04","current":-1.079516,"twenty":-4.057747,"median":-1.983517,"eighty":-1.761468,"marketCap":93261504},{"date":"2026-09-11","current":-0.993987,"twenty":-3.928626,"median":-1.973761,"eighty":-1.751149,"marketCap":85872559},{"date":"2026-09-18","current":-0.991772,"twenty":-3.863157,"median":-1.97142,"eighty":-1.742209,"marketCap":85681136},{"date":"2026-09-25","current":-0.992658,"twenty":-3.783142,"median":-1.969228,"eighty":-1.735768,"marketCap":85757705},{"date":"2026-10-01","current":-0.93106,"twenty":-3.718472,"median":-1.957787,"eighty":-1.713738,"marketCap":80436133}],"updateTime":1790957703443},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672767349","title":"Pelthos Therapeutics Hosts Annual Shareholder Meeting, Quorum Present","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767349","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767349?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:15","pubTimestamp":1790889359,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics hosts annual shareholder meeting, quorum presentPelthos Therapeutics held its annual shareholder meeting on Sept. 29, 2026.Shareholders backed the appointment of Grant Thornton LL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL52H9kM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672522677","title":"OS Therapies Names Kerry Clem Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672522677","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672522677?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:33","pubTimestamp":1790857995,"startTime":"0","endTime":"0","summary":"OS Therapies names Kerry Clem chief commercial officerOS Therapies appointed Kerry Clem as chief commercial officer to lead U.S., U.K., and European launch planning for Herlystic.Clem previously serve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2CRFtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234617","title":"Analysts Offer Insights on NA Companies: Flex (FLEX), Howard Hughes Holdings (HHH) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234617?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 3 analysts just weighed in on Flex (FLEX), Howard Hughes Holdings (HHH) and Pelthos Therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-flex-flex-howard-hughes-holdings-hhh-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-flex-flex-howard-hughes-holdings-hhh-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4512","LU1548497426.USD","LU0208291251.USD","LU1720051108.HKD","BK4141","LU0069063385.USD","LU1366192091.USD","LU2272731782.SGD","LU2357305700.SGD","BK4145","FLEX","NA","LU0057025933.USD","LU1992135472.HKD","HHH","BK4139","LU0511384066.AUD","LU2098885051.SGD","LU0289960550.SGD","PTHS","LU0320765489.SGD","LU0963586101.USD","LU2322448957.HKD","LU1992135399.USD","LU0070302665.USD","LU0472753341.HKD","LU2473716301.USD","LU0289961442.SGD","LU2322448791.USD","LU2272731600.USD","LU0124676726.USD","LU1720051017.SGD","LU2272731865.HKD","LU0054578231.USD","LU0289739343.SGD","BK4588","BK4024","LU1303367103.USD","LU0175139822.USD","BK4585","LU0689626769.HKD","FLEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665452327","title":"Analysts Offer Insights on NA Companies: Pelthos Therapeutics (PTHS) and X-Energy, Inc. Class A (XE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665452327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665452327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Pelthos Therapeutics (PTHS) and X-Energy, Inc. Class A (XE) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-pelthos-therapeutics-pths-and-x-energy-inc-class-a-xe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-pelthos-therapeutics-pths-and-x-energy-inc-class-a-xe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XE","BK4139","PTHS","NA","BK4141","SOCL","BK4182"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2661275185","title":"Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275185?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:35","pubTimestamp":1787571349,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners reiterated a Buy rating on Pelthos Therapeutics, with a price target of $45....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-reaffirms-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-reaffirms-their-buy-rating-on-pelthos-therapeutics-pths-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492069","title":"Pelthos Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492069?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:01","pubTimestamp":1787086907,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics announces annual shareholder meetingPelthos Therapeutics will hold its 2026 annual shareholder meeting online on Sept. 29, 2026.Shareholders will vote to elect eight directors to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL24dCQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659499201","title":"Scienture Q2 Revenue Surges on Rezenopy Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2659499201","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659499201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:17","pubTimestamp":1786709821,"startTime":"0","endTime":"0","summary":"Scienture Q2 revenue surges on REZENOPY launchOverviewUS specialty pharma firm's Q2 revenue rose sharply, driven by commercial launch of REZENOPYQ2 gross margin reached 97.7%, reflecting growing comme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4139","OMER","PTHS","SCNX","BK4007","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169726","title":"Pelthos Therapeutics (PTHS) Gets a Buy from Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169726?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:35","pubTimestamp":1786642545,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners maintained a Buy rating on Pelthos Therapeutics, with a price target of $45....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-alliance-global-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659655651","title":"Pelthos Therapeutics Falls as Co Says Will Restate Q1 Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2659655651","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659655651?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:18","pubTimestamp":1786634323,"startTime":"0","endTime":"0","summary":"BUZZ-Pelthos Therapeutics falls as co says will restate Q1 financial statements** Shares of Pelthos TherapeuticsPTHS.Afall 1.8% to $28.41 in morning trade** Pelthos says has it has identified a materi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL6N44A13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315736","title":"Biofrontera Q2 Revenue Rises on Higher Volume, Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315736","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315736?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:01","pubTimestamp":1786626085,"startTime":"0","endTime":"0","summary":"Biofrontera Q2 revenue rises on higher volume, pricingOverviewU.S. biopharmaceutical firm's Q2 revenue grew 33% yr/yr, driven by higher unit volume and pricingNet loss for Q2 narrowed to $0.6 mln from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BFRI","PTHS","BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159221","title":"Pelthos Therapeutics Posts Investor Deck Outlining Dermatology Portfolio Strategy Centered on Zelsuvmi Launch, Xepi and Xeglyze Additions","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159221?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:34","pubTimestamp":1786620880,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics posts investor deck outlining dermatology portfolio strategy centered on Zelsuvmi launch, Xepi and Xeglyze additionsPelthos highlighted commercial traction for Zelsuvmi, with more","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8Q2Y5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159826","title":"Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159826","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159826?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:20","pubTimestamp":1786620006,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoptionOverviewU.S. biopharmaceutical firm's Q2 net product revenue grew 45% quarter-over-quarterNet loss for Q2 narrowed compared to Q1, adjusted EB","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OMER","PLX","LQDA","BK4007","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156416","title":"Pelthos Q2 FY26 Net Loss Narrows to $23.42 Million; Net Product Revenue Climbs 45% to $15.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156416","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156416?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619425,"startTime":"0","endTime":"0","summary":"Pelthos Q2 FY26 net loss narrows to $23.42 million; net product revenue climbs 45% to $15.4 millionPelthos posted a GAAP net loss of USD 23.4 million, narrowing from USD 25.1 million in the prior quar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2Y5Dcz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","BCDF","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","PTHS","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659468156","title":"Pelthos Therapeutics Q2 Net Income USD -23.417 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659468156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659468156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLX7BCVP8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156466","title":"Pelthos Therapeutics Announces Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156466?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA8RN9YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659561321","title":"Pelthos Therapeutics Restates Q1 2026 Net Loss to USD 25.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659561321","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659561321?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:07","pubTimestamp":1786619257,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics restates Q1 2026 net loss to USD 25.07 millionPelthos filed a Form 10-Q/A on Aug. 13, 2026, restating unaudited first-quarter 2026 financial statements due to ASC 820 valuation er","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3FP2CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715699","title":"Pelthos Restates Q1 Results After ASC 820 Error Lifts Convertible Debt Fair Value by $15.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715699","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619155,"startTime":"0","endTime":"0","summary":"Pelthos restates Q1 results after ASC 820 error lifts convertible debt fair value by $15.8 millionPelthos flagged non-reliance on its Q1 2026 Form 10-Q due to a misapplication of ASC 820 in Level 3 fair values.Restatement will lift the fair value of convertible debt by $15.8 million, raising liabilities and widening accumulated deficit by $14.8 million.Non-cash expense tied to the convertible debt fair value change will increase by $14.8 million, pressuring reported net loss.Audit committee identified a material weakness in controls over valuation and review of Level 3 measurements tied to the convertible debt.No expected impact on liquidity, cash, revenue, operating expenses, or operating loss; correction sits in other income .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8Qz3Fq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659565561","title":"Pelthos Therapeutics - Restatement Will not Impact Liquidity or Cash Position for Quarter Ended March 31, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659565561","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659565561?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659563971","title":"Pelthos Therapeutics - Financial Statements Should no Longer be Relied upon for Quarter Ended March 31- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659563971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659563971?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156653","title":"Pelthos Therapeutics - Identifies Material Weakness in Internal Control as of March 31, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156653?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:02","pubTimestamp":1786618929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}